Pharmaceuticals, Biotechnology and Life Sciences
Actinium Pharmaceuticals has applied an Investigational New Drug for Actimab-A combined with CLAG-M, for Acute Myeloid Leukemia, to the USFDA.
Audentes Therapeutics has started with dosing of patients in a Phase 1/2 clinical trial of its product candidate AT342 for…
Santen’s topline results from the Phase I/II study of DE-122 for refractory wet age-related macular degeneration (AMD) suggest bioactivity of DE-122…
Reata Pharmaceuticals has reported that its study that shows bardoxolone methyl can improve kidney functions for patients with pulmonary arterial…
ImmunoMet Therapeutics, a private US-based biotechnology company, on Monday appointed two new executives, for medical and financial departments.
Xeris Pharmaceuticals got its third orphane drug designation from the USFDA, this time for its treatment of Hyperinsulinemic Hypoglycemia.
BioPorto and Roche agreed that BioPorto will deliver a neutrophil gelatinase-associated lipocalin (NGAL) test for use on Roche’s cobas c…
Aquinox Pharmaceuticals has completed the list of candidates to be included in the clinical trial of its bladder pain syndrome…
Immutep Limited’s combination of eftilagimod alpha with pembrolizumab (KEYTRUDA) is safe and well tolerated at doses up to 30 mg…
ViiV Healthcare on Thursday said it has filed patent infringement litigation against Gilead Sciences Inc. over bictegravir in the United…